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Aberrant stress and inflammatory responses are key
factors in the pathogenesis of obesity and metabolic
dysfunction, and the double-stranded RNA-depen-
dent kinase (PKR) has been proposed to play an
important role in integrating these pathways. Here,
we report the formation of a complex between PKR
and TAR RNA-binding protein (TRBP) during meta-
bolic and obesity-induced stress, which is critical
for the regulation of eukaryotic translation initiation
factor 2 alpha (eIF2a) phosphorylation and c-Jun
N-terminal kinase (JNK) activation. We show that
TRBP phosphorylation is induced in the setting of
metabolic stress, leading toPKRactivation. Suppres-
sion of hepatic TRBP reduced inflammation, JNK
activity, and eIF2a phosphorylation and improved
systemic insulin resistance and glucose metabolism,
while TRBP overexpression exacerbated the impair-
ment in glucose homeostasis in obese mice. These
data indicate that the association between PKR and
TRBP integrates metabolism with translational con-
trol and inflammatory signaling and plays important
roles in metabolic homeostasis and disease.
INTRODUCTION
It is established that obesity coexists with a state of metabolic
inflammation, also called metaflammation (Hotamisligil, 2006),
in which excess nutrients trigger inflammation and stress
responses, including recruitment of immune cells into metabolic
tissues, activation of IkB kinase (IKK) and c-Jun N-terminal ki-
nase (JNK) pathways, and elevated production of an array of
immunemediators (Donath and Shoelson, 2011; Gregor and Ho-tamisligil, 2011; Lumeng and Saltiel, 2011; Olefsky and Glass,
2010; Pedersen and Febbraio, 2010; Sabio and Davis, 2010).
Inflammation is a central adaptive and repair mechanism essen-
tial for tissue homeostasis and survival (Wernstedt Asterholm
et al., 2014). However, chronic and systemic activation of
inflammatory and stress signaling pathways underlies metabolic
pathologies such as insulin resistance, type 2 diabetes, and
atherosclerosis (Glass and Olefsky, 2012; Jin et al., 2013). A crit-
ical mechanism for metabolic dysfunction in obesity also in-
volves ER stress and dysfunction through direct actions on
both insulin signaling and pathways controlling glucose, lipid,
and protein metabolism and in crosstalk with inflammatory
signaling pathways (Hotamisligil, 2010). However, it remains un-
clear how these diverse stress pathways are activated, inte-
grated, and coupled to the regulation of protein translation and
metabolic homeostasis under conditions of metabolic challenge.
The unfolded protein response (UPR) is engaged during ER
stress as an adaptive response and an attempt to restore ho-
meostasis by suppression of global protein synthesis, stimula-
tion of protein degradation, and synthesis of components of
the folding machinery (Hetz, 2012; Malhi and Kaufman, 2011;
Ron and Walter, 2007). However, chronic ER stress and the re-
sulting dysfunctional UPR, in a manner similar to a prolonged in-
flammatory response, also contribute to pathology, including
metabolic deterioration and disease (Fonseca et al., 2011; Malhi
and Kaufman, 2011; Hotamisligil, 2010). One common strategy
of cells to control translation during stress is the induction
of eIF2a phosphorylation mediated by at least four kinases:
double-stranded RNA-dependent kinase (PKR), PKR-like endo-
plasmic reticulum kinase (PERK), heme-regulated inhibitor
kinase (HRI), and general control nonrepressed 2 (GCN2)
(Holcik and Sonenberg, 2005). This pathway is ubiquitously
engaged in metabolic tissues such as liver in both obese
humans and experimental models, resulting in increased eIF2a
phosphorylation and downregulation of global protein synthesis
accompanied by reduced polyribosome activity (Fu et al., 2011;Cell Reports 11, 295–307, April 14, 2015 ª2015 The Authors 295
Gregor et al., 2009; Karinch et al., 2008; Sharma et al., 2008).
Similarly, JNK activation (Blu¨her et al., 2009; Ferna´ndez-Veledo
et al., 2009; Hirosumi et al., 2002; Sourris et al., 2009; Vallerie
and Hotamisligil, 2010) and metaflammation (Gregor and Hota-
misligil, 2011; Odegaard and Chawla, 2013) are essentially
universal to experimental and human obesity and critical for
metabolic deterioration. Despite the importance of these
signaling events in metabolic homeostasis, the molecular mech-
anisms by which these stress signaling pathways converge in
obesity remain unknown.
We have recently shown that PKR, a pathogen-sensing pro-
tein, is activated by excess nutrients and that its aberrant activity
plays a key role in metabolic abnormalities under stress (Naka-
mura et al., 2014; Nakamura et al., 2010). Similar observations
were made in an independently derived strain of PKR-deficient
mice (Carvalho-Filho et al., 2012). Importantly, PKR is involved
in eIF2a phosphorylation in mice fed a high-fat diet and is a crit-
ical component of inflammasome activation (Lu et al., 2012; Na-
kamura et al., 2010), raising the possibility that PKRmay function
as a common node that responds to both pathogen- and
nutrient-induced inflammatory and stress signals in order to
suppress insulin action and regulate protein translation under
metabolic stress conditions. Exposure of cells and tissues to lip-
otoxicity also leads to PKR activation and PKR-dependent JNK
activation, raising the possibility that PKR serves as a sensor for
metabolic stress signals. Indeed, PKR activity and JNK phos-
phorylation are elevated in multiple tissues in obese humans
(Boden et al., 2008; Carvalho et al., 2013; Gregor et al., 2009;
Sourris et al., 2009), strongly suggesting that this role of PKR is
conserved and relevant to human disease. However, the mech-
anism that underlies the assembly of an active PKR complex,
and how this complex is coupled to metaflammation, transla-
tional suppression, and metabolic dysregulation in obesity, re-
main unknown. Here, we show that metabolic stress triggers
the formation of a PKR complex that features RNA-induced
silencing complex (RISC)-loading complex (RLC) proteins and
TRBP, resulting in PKR activation and metabolically induced
eIF2a phosphorylation, JNK activation, and related inflammatory
responses.
RESULTS
Identification of the Components of the PKR Protein
Complex in Liver
We and others previously reported that PKR is activated in
mouse and human tissues in obesity (Carvalho et al., 2013;
Carvalho-Filho et al., 2012; Nakamura et al., 2010), although
the molecular mechanism that underlies this activation remains
to be elucidated. We hypothesized that a unique PKR-containing
protein complex forms in the obese condition and that the
complex component(s) may impact PKR activity, inflammatory
responses, and protein translation in obesity. To address this
question, we performed biochemical purification and identifica-
tion of the PKR protein complexes from the liver tissues of lean
and obese (ob/ob) mice. We utilized an adenovirus-mediated
gene transfer method to deliver hemagglutinin (HA)-tagged
PKR into the liver and purified PKR-containing complexes from
these compartments using an agarose-conjugated anti-HA296 Cell Reports 11, 295–307, April 14, 2015 ª2015 The Authorsmonoclonal antibody (Figure 1A). Then, we determined the
PKR-associated proteins by exhaustive rounds of ‘‘shotgun’’
liquid chromatography and tandem mass spectrometry (LC-
MS/MS) for protein identification and quantification (Figures 1B
and 1C). These experiments were performed as three indepen-
dent biological replicates, and statistical analysis of fold-change
values (t tests) was used to distinguish PKR-interacting proteins
from background signals with high confidence (red and gray
dots, respectively, Figures 1B and 1C; Tables S1 and S2).
Among the high-confidence PKR interaction molecules, we
detected known partners of PKR such as eIF2a (also referred
to as eIF2S1), validating our experimental system. PKR has
been shown to be a pathogen sensor through its recognition
of pathogen-derived double-stranded RNA (dsRNA) (Robertson
and Mathews, 1996). Given that PKR interacts with various
proteins involved in RNA processing and biology in the
liver, we hypothesized that PKR might be closely integrated
with endogenous RNA processing components, particularly
under metabolic stress conditions. To test this hypothesis, we
analyzed the list of high-confidence PKR interactors in lean
and obese liver tissue through enriched Gene Ontology (GO) in
biological processes and molecular function categories (Fig-
ure 1D). Enriched GO terms common to lean and obese samples
included RNA processing, RNA binding, and protein translation.
Interestingly, the functional clades enriched only in the lean sam-
ples were found to be associated with metabolism and cellular
maintenance, while many of the GO terms enriched only in the
obese samples were related to RNA splicing and mRNA pro-
cessing (Figure 1D). These results support the assembly of
distinct protein complexes in lean and obese liver tissue and
suggest the possibility that PKR complexes detected in liver tis-
sue of obese animals may have specialized metabolic functions.
In an additional analytical approach, we also considered
all PKR-exclusive proteins, i.e., proteins categorized with a
log2(PKR/GFP) ratio over 35, with the postulate that some of
the PKR-exclusive proteins may also be of unique functional
interest. This analysis yielded additional proteins involved in
the regulation of RNA splicing and mRNA metabolism in the
samples from obese animals including Dicer, a known compo-
nent of the RLC (Czech and Hannon, 2011; Kim et al., 2009),
which was observed as a PKR-interacting protein preferentially
in obesity (Tables S1 and S2). To confirm the interaction,
we performed co-immunoprecipitation experiments and found
that the PKR-Dicer interaction was enhanced in the liver in
the context of obesity (Figure 1E). Mammalian Dicer also inter-
acts with two closely related proteins, TAR RNA-binding pro-
tein (TRBP) and PACT (Chendrimada et al., 2005; Kim et al.,
2009; Lee et al., 2006), which in turn regulate Dicer stability
and contribute to RLC formation (Kok et al., 2007). In addition,
both PACT and TRBP have been shown to interact with PKR,
although their significance in inflammatory responses and
metabolic regulation is not known and no studies have been
conducted to explore their function in obesity (Clerzius et al.,
2011). We found that PKR interacted with TRBP in liver upon
exogenous PKR expression and that this interaction was en-
hanced in obese animals (Figure 1E). To evaluate the formation
of endogenous complex, we pulled down TRBP from liver
lysate and performed western blot analyses with anti-PKR
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Figure 1. Identification of Hepatic PKR Protein Complex in Lean and Obese Mice
(A) Silver staining of PKR-associated proteins following immunoprecipitation from lean and obese liver.
(B and C) Results of mass spectrometry analyses for identification of PKR protein complexes in lean and obese (ob/ob) mice. Vertical hashed lines indicate a fold
change of 10 (or10), horizontal hashed lines indicate a corrected p value of 0.05. Proteins are distributed into two distinct populations based on exclusivity, i.e.,
molecules found only in the PKR, but not in the control, samples (or vice versa) center at log2(PKR/GFP) ratio of >35. See also Tables S1 and S2.
(D) Gene ontology analysis of statistically significant PKR interactors in liver of lean and obese mice.
(E) Physical interaction between PKR and components of RLC, TRBP and Dicer, in liver of lean and obesemice. The graph on the right shows the quantification of
the TRBP-PKR interaction and PKR-Dicer interaction. Data are shown as the mean ± SEM (n = 3). *p < 0.05. See also Figure S1A.and Dicer antibodies. In this setting, TRBP interaction with PKR
was similarly enhanced in the setting of obesity (Figure S1A).
PKR Activation Promotes Formation of a Functional
Complex
Given that the interactions among PKR, Dicer, and TRBP are
enhanced in obesity, a condition in which PKR is also highly acti-
vated, we hypothesized that these interactions may be required
for or dependent on PKR activity. To investigate these possibil-
ities, we next examined whether treatment with polyinosinic-pol-
ycytidylic acid poly(I:C), which mimics virus-derived dsRNA and
is one of the strongest known PKR activators (Garcı´a et al.,
2006), leads to enhanced association between PKR and RLC
components. As shown in Figure 2A, poly(I:C) treatment resulted
in enhanced interaction among PKR, Dicer, and TRBP in mouse
embryonic fibroblasts (MEFs). Similarly, Dicer interaction with
PKR was enhanced when PKR was activated by poly(I:C) in he-
patocytes (Figure S1B).
To further investigate the mechanisms and consequences of
the PKR-TRBP and Dicer interactions, we used PKR-deficient
MEFs reconstituted with Flag-tagged PKR. The exogenousPKR expression level in Pkr/MEFs was comparable to endog-
enous PKR in Pkr+/+ MEFs and was unaffected by poly(I:C) treat-
ment (Figure 2B). Poly(I:C) treatment enhanced the interaction
between PKR and endogenous Dicer and TRBP, and formation
of this ternary complex was further strengthened in the presence
of exogenous TRBP protein (Figure 2C). Since PKR’s N-terminal
region, which contains two dsRNA-binding domains, mediates
intermolecular interactions (Cosentino et al., 1995), we asked
whether RNA-binding activity of PKR was critical for the interac-
tion between PKR and RLC. We reconstituted Pkr/MEFs with
wild-type (WT) and RNA-binding defective PKR (RD), which has
point mutations on lysines 64 and 154 in the RNA-binding motifs.
A kinase-dead (KD) mutant, which has a point mutation on its
lysine 296 residue in the kinase domain, was used as an addi-
tional control. The RD mutant lost the ability to interact with
TRBP and Dicer, both at baseline and following poly(I:C) stimu-
lation (Figure 2D), suggesting that PKR RNA-binding capacity
may be required for formation of a ternary complex with Dicer
and TRBP. Although the interaction among KD-PKR, Dicer,
and TRBP was weaker than that of WT-PKR, this mutant still re-
tained some residual ability to interact with Dicer and TRBP in theCell Reports 11, 295–307, April 14, 2015 ª2015 The Authors 297
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Figure 2. The Role of RLC in Regulation of
PKR Kinase Activity and Induction of eIF2a
Phosphorylation
(A) Physical interaction among endogenous PKR,
Dicer, and TRBP in MEFs in the presence of
poly(I:C). Pkr+/+ and Pkr/ MEFs were treated
with 1 mg/ml poly(I:C) for 1 hr, followed by immu-
noprecipitation and western blots with antibodies
as indicated. The graph on the right shows the
quantification of the TRBP-PKR interaction. Data
are shown as the mean ± SEM (n = 3). **p < 0.01.
See also Figure S1B.
(B) Expression level of PKR in MEFs. Flag-tagged
PKR was introduced by retrovirus-mediated gene
transfer in Pkr/ MEFs.
(C) Physical interaction among PKR, Dicer, and
TRBP in MEF cells. Cell lysates were prepared
from Pkr/ MEFs reconstituted with retrovirally
expressed Flag-tagged wild-type (WT) PKR and
HA-tagged TRBP in the absence or presence of
1 mg/ml poly(I:C). SE, short exposure; LE, long
exposure.
(D) Effects of mutations in PKR’s RNA-binding and
kinase domains on formation with the PKR-RLC.
Cell lysates were prepared from Pkr/ MEFs
reconstituted with vector (V), Flag-tagged WT
PKR (WT), RNA-binding defective PKR (RD), and
kinase-dead mutant (KD) in the absence or pres-
ence of 1 mg/ml poly(I:C) for 1 hr.
(E) Effects of mutations of PKR on PKR kinase
activity. PKR activity was assessed with cell ly-
sates used in Figure 2D using recombinant eIF2a
protein.
(F) Interaction of RLC with PKR. Cell lysates were
prepared from Pkr/ MEFs reconstituted with WT PKR and HA-tagged TRBP in the absence or presence of 1 mg/ml poly(I:C) for 1 hr.
(G) Ability of TRBP to induce eIF2a phosphorylation through recruitment of PKR. In vitro kinase assay was performed with cell lysates used in Figure 2F using
recombinant eIF2a protein.presence of poly(I:C) (Figure 2D). Importantly, although the RD
mutant has an intrinsically intact kinase activity in vitro (data
not shown), it did not exhibit poly(I:C)-induced PKR activation
(Figure 2E), suggesting that formation of a complex with TRBP
and Dicer may be important for induction of PKR activity and
its downstream functions in this context, including translational
and metabolic regulation through eIF2a phosphorylation.
To determine the potential impact of TRBP on eIF2a phos-
phorylation, we performed immunoprecipitation experiments to
pull down TRBP from MEFs expressing HA-tagged TRBP in
the presence or absence of PKR. As shown in Figure 2F, TRBP
interacted with PKR only when the cells were stimulated by
poly(I:C). Importantly, stimulated interaction of TRBP with PKR
did not affect the intensity of interaction between TRBP and
Dicer. In this setting, as above, poly(I:C) stimulation of complex
formation resulted in robust eIF2a phosphorylation (Figure 2G).
These data implicate the potential involvement of TRBP in trans-
lational regulatory pathways through PKR-mediated induction of
eIF2a phosphorylation.
TRBP Is Involved in Palmitate-Induced PKR Activation
We previously reported that PKR is activated by palmitate
exposure and that the RNA-binding activity of PKR is required
for palmitate-induced PKR activation (Nakamura et al., 2010).298 Cell Reports 11, 295–307, April 14, 2015 ª2015 The AuthorsThus, we asked whether lipid exposure also triggers the interac-
tion between PKR and the RLC to link this potential mechanism
to a metabolic context. As shown in Figure 3A, palmitate treat-
ment resulted in increased interaction between PKR and RLC
components, TRBP and Dicer. These interactions also required
PKR RNA-binding activity, as they were lost in cells expressing
the RD-PKR mutant (Figure 3B). Thus the interaction between
PKR and RLCmay also be responsive to nutrient-induced meta-
bolic stress and PKR activation levels.
We also examined whether other fatty acids could affect PKR
activity. To address this question, we treated Pkr/ MEFs ex-
pressing WT-PKR with four different saturated fatty acids (lau-
rate, myristate, palmitate, and stearate) and an unsaturated
fatty acid (oleate), followed by PKR kinase assay. As shown
in Figure S2A, PKR activity was induced by relatively longer
fatty acids palmitate and stearate. Importantly, although the
number of carbon atoms is the same between stearate and
oleate, oleate was a less effective PKR activator than stearate.
As longer saturated fatty acids are intrinsically prone to induce
metabolic inflammation compared to unsaturated fatty acids,
these data indicate that PKR activity may be a reflection of
the level of metabolic stress within cells. Indeed, we observed
that eicosapentaenoic acid (EPA) and palmitoleate, unsaturated
fatty acids known to lower inflammation and improve metabolic
A B
C
D
F
E
Figure 3. Association of TRBP with PKR in Palmitate-Induced Metabolic Stress
(A) Physical interaction between endogenous PKR and Dicer in MEFs in the presence of palmitate. Pkr+/+ and Pkr/MEFs were treated with 100 mM palmitate
(PA) for 1 hr, followed by immunoprecipitation and immunoblotting with antibodies as indicated. The graph on the right shows the quantification of PKR-TRBP
interaction. Data are shown as the mean ± SEM (n = 4). *p < 0.05.
(B) Physical interaction between PKR, Dicer, and TRBP in MEF cells after palmitate exposure. Pkr/MEFs reconstituted with retrovirally expressed Flag-tagged
WT or RD PKR were treated with 100 mM palmitate, followed by immunoprecipitation with anti-Flag antibody.
(C) Palmitate-induced physical interaction between PKR and TRBP in MEF cells pretreated with 100 mM EPA for 14 hr. Pkr/ MEFs reconstituted with Flag-
tagged WT PKR (WT) were cultured in the presence of 100 mM EPA for 14 hr. These cells were treated with 100 mM palmitate for 2 hr at the end of EPA culture
period. See also Figures S2A–S2C.
(D and E) Effects of Dicer or TRBP deficiency on palmitate-induced PKR activation. Dicer (D) and TRBP (E) knockout fibroblasts and their control cells were treated
with 100 mMpalmitate for 2 hr, followed by in vitro PKR kinase assay. Blots shown are representative of three independent experiments; graphs are mean ± SEM
(n = 3). *p < 0.05.
(F) TRBP deficiency results in reduced palmitate-induced JNK and eIF2a phosphorylation levels. TRBP-knockout fibroblasts and control cells were treated
with 100 mMpalmitate for 2 hr, followed bywestern blot analysis. Blots shown are representative of four independent experiments; graphs aremean ±SEM (n = 4).
*p < 0.05.homeostasis (Cao et al., 2008; Li et al., 2013; Spann et al.,
2012), did not activate PKR and diminished palmitate-induced
PKR activation (Figures S2B and S2C). Consistent with these
observations, palmitate-enhanced interaction between PKR
and TRBP was also blocked in the presence of these unsatu-
rated fatty acids (Figure 3C).
Given that PKR interacts with the RLC in response to meta-
bolic stress, we next examined whether RLC components
are critical for palmitate-induced PKR activation. As shown
in Figure 3D, palmitate-induced PKR activation was intact in
Dicer-deficient MEFs, although the magnitude was moderate.
However, palmitate treatment failed to activate PKR in the
absence of TRBP (Figure 3E). This is an unexpected result,
as TRBP can act as an inhibitor of PKR (Clerzius et al.,2011; Park et al., 1994). Numerous experiments have indi-
cated that PKR is also required for JNK activation in vitro
and in vivo (Carvalho-Filho et al., 2012; Goh et al., 2000; Na-
kamura et al., 2010; Takada et al., 2007). Consistent with a
role for TRBP in PKR activation, palmitate-induced JNK acti-
vation, which is also moderate in these cells, as well as
eIF2a phosphorylation were diminished in TRBP-deficient fi-
broblasts (Figure 3F). Taken together, these data suggest
that although TRBP has been previously considered as an in-
hibitor of PKR in certain contexts (Clerzius et al., 2011; Park
et al., 1994), its function appears to be more diversified and
is regulated by metabolic stress. Furthermore, these observa-
tions indicate a requirement for PKR-TRBP complex formation
in the activation of PKR in response to nutrient signals andCell Reports 11, 295–307, April 14, 2015 ª2015 The Authors 299
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Figure 4. Role of TRBP Phosphorylation on PKR Activity
(A) Schematic domain structure of TRBP with arrows indicating the positions of four serine (S) phosphorylation residues as shown previously (Paroo et al., 2009).
Abbreviations of TRBP mutants used in this paper are indicated below.
(B) Effect of co-expression of constitutively active JNK1 (MKK7-JNK1) with WT or TRBP SA mutants on their mobility shifts detected by anti-TRBP antibody.
(C) Interaction between PKR and TRBP variants in Pkr/ MEFs. PKR and TRBP variants were examined by immunoprecipitation followed by immunoblotting.
(D) PKR activity in Pkr/ MEFs reconstituted with Flag-tagged WT PKR retrovirally expressing WT, 4SA, or 4SD TRBP. The graph on the right shows the
quantification of the results. Data are shown as the mean ± SEM (n = 3). *p < 0.05.
(E) Palmitate-induced TRBP phosphorylation levels. WT MEFs and TRBP-deficient fibroblasts were treated with 100 mM palmitate for 2 hr, followed by immu-
noprecipitation with anti-TRBP antibody and western blot analysis with anti-phospho TRBP (ser152) antibody. Blots shown are representative of three inde-
pendent experiments; graphs are mean ± SEM (n = 3). *p < 0.05. See also Figures S3A and S3B.
(F) TRBP phosphorylation levels in liver of WT and leptin-deficient obese mice. The graph on the right shows the quantification of the results. Data are shown as
the mean ± SEM (n = 5). *p < 0.05.key downstream events such as JNK activation and eIF2a
phosphorylation.
TRBP Phosphorylation Links Metabolic Stress to PKR
Activation
In the context of interferon-induced PKR activation, it has been
proposed that TRBP inhibits PKR function both by dsRNA
sequestration and by direct protein-protein interaction (Benkir-
ane et al., 1997; Park et al., 1994). In contrast, we describe above
that metabolic stress induces interaction between TRBP and
PKR, leading to PKR activation and suggesting a dual regulatory
role for TRBP, as has been reported for some other components
of the RLC (Clerzius et al., 2013; Diederichs and Haber, 2007). In
an attempt to gain mechanistic insights into TRBP function, we
asked whether a post-translational modification of TRBP might
alter its interaction with PKR and differentially regulate its activ-
ity. Recently, Paroo et al. reported that four serine residues of
TRBP are phosphorylated by the mitogen-activated protein ki-
nase ERK (Figure 4A) (Paroo et al., 2009). In agreement with
this report, we found that expression of constitutively active
JNK (MKK7-JNK1) also induced phosphorylation of TRBP, and
we determined that this modification occurred predominantly
on two of the previously identified residues, S142 and S152 (Fig-
ure 4B). Remarkably, phospho-mimetic (serine-to-aspartate
[SD]) variants of TRBP robustly interacted with PKR in the300 Cell Reports 11, 295–307, April 14, 2015 ª2015 The Authorsabsence of additional stimuli (Figure 4C). Conversely, the inter-
action of the 4SD mutant with the RD-PKR mutant was much
weaker than that with WT-PKR (Figure 4C), suggesting that
PKR RNA-binding activity may be critical for the interaction be-
tween PKR and TRBP.
Next, we examined the effect of TRBP phosphorylation on
PKR kinase activity. In reconstituted Pkr-deficient MEFs,
expression of the 4SA TRBP mutant, a non-phospho-mimetic
(serine-to-alanine [SA]) variant, moderately suppressed PKR
activity, while the 4SD TRBP mutant lacked this activity (Fig-
ure 4D). These data suggest that TRBP phosphorylation in this
context may be important not only for interaction with PKR
but also for PKR activity. Next, we generated a phospho-spe-
cific TRBP antibody that specifically detects TRBP’s phos-
pho-serine 152 residue and confirmed specificity by mutational
analysis (Figure S3A). Using this antibody, we determined TRBP
phosphorylation status upon induction of metabolic stress. As
shown in Figure 4E, the level of TRBP serine 152 phosphoryla-
tion was increased by palmitate exposure, and TRBP phosphor-
ylation was also observed in MEFs treated with poly(I:C)
(Figure S3B). We then asked whether TRBP phosphorylation
was present in the setting of obesity, a context in which PKR
is activated (Nakamura et al., 2010). Indeed, we observed
TRBP serine 152 phosphorylation in the liver of obese mice (Fig-
ure 4F). These data suggest that TRBP phosphorylation occurs
A B C
D E F
G
H
Figure 5. Improved Glucose Metabolism and Insulin Sensitivity in Pkr-Deficient ob/ob Mice
(A) Effects of Pkr deficiency on body weight in ob/ob mice.
(B) Glucose tolerance tests, performed in Pkr+/+ob/ob (n = 12) and Pkr/ob/ob (n = 7) mice at 7 weeks of age. Data are shown as the mean ± SEM. *p < 0.05.
(C) Insulin tolerance tests, performed in Pkr+/+ob/ob (n = 12) and Pkr/ob/ob (n = 7) mice at 9 weeks of age. Data are shown as the mean ± SEM. *p < 0.05.
(D and E) Blood glucose (D) and serum insulin (E) levels after 14 hr food withdrawal in Pkr+/+ (n = 8), Pkr/ (n = 8), Pkr+/+ob/ob (n = 8), and Pkr/ob/ob (n = 8) mice
at 10 weeks of age. Date are shown as the mean ± SEM. *p < 0.05. See also Figures S4A–S4C.
(F and G) JNK1 kinase activity (F), which was measured by a kinase assay using immunopurified JNK1, ATP[g-32P], and recombinant c-Jun protein as substrate,
and phosphorylation level of eIF2a on serine 52 (G), which was detected by anti-phospho-eIF2a antibody, in liver of Pkr/, Pkr+/+ob/ob, and Pkr/ob/obmice
at 10 weeks of age. The graph on the right shows the quantification of the results. Data are shown as the mean ± SEM. *p < 0.05. See also Figure S4D.
(H) Phosphorylation levels of IRS1 on serine 307 detected by anti-phospho IRS1 antibody. The graph on the right shows the quantification of the results. Data are
shown as the mean ± SEM. *p < 0.05.in response to metabolic stress and is associated with PKR
activity.
Metabolic Functions of the PKR-TRBP Axis in Obese
Liver
Independent studies previously showed that PKR-deficient mice
fed a high-fat diet demonstrate reduced JNK activation and
eIF2a phosphorylation and are protected against obesity and in-
sulin resistance (Carvalho-Filho et al., 2012; Nakamura et al.,
2010). Direct regulation of insulin sensitivity and JNK activation
by PKR was also shown using a short-term lipid infusion model
(Nakamura et al., 2010). In an attempt to generate a new model
to test PKR’s effects on JNK activation, eIF2a phosphorylation,
and glucose metabolism, we intercrossed PKR-deficient micewith the ob/obmodel, which displays severe obesity with insulin
resistance and hyperglycemia. Importantly, in the C57BL/6J-ob/
ob genetic background, Pkr/ and Pkr+/+ mice exhibited similar
body weights (Figure 5A) with only aminor difference in adiposity
(data not shown). However, in glucose tolerance tests (GTTs),
Pkr/ob/obmice showed significantly improved glucose clear-
ance after a glucose challenge compared to controls at 7 weeks
of age (Figure 5B). Similarly, during insulin tolerance tests
(ITTs), 9-week-old Pkr/ob/obmice were more insulin sensitive
than Pkr+/+ob/ob (Figure 5C). Consistent with these observa-
tions, fasting blood glucose levels of ob/ob mice lacking PKR
were significantly lower than those of Pkr+/+ob/ob controls,
while serum insulin levels were comparable between the groups
(Figures 5D and 5E). In addition, levels of circulating triglyceride,Cell Reports 11, 295–307, April 14, 2015 ª2015 The Authors 301
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Figure 6. Effects of Hepatic TRBP Expression on Glucose Metabolism and eIF2a Phosphorylation in a Genetic Model of Obesity
(A and B) Effects of hepatic TRBP expression in ob/ob mice on body weight (A) and liver weight (B). Data are shown as the mean ± SEM (n = 8).
(C) Effect of hepatic TRBP expression in ob/ob mice on fasting blood glucose. Data are shown as the mean ± SEM (n = 8). *p < 0.05.
(D) Effects of hepatic TRBPexpression on systemic glucosemetabolismassessed by glucose tolerance tests. Data are shownas themean±SEM (n = 8). *p < 0.05.
(E and F) Effects of hepatic TRBP expression on JNK and eIF2a phosphorylation. Phosphorylation levels of eIF2a and JNK were detected by anti-phospho-
antibodies in liver lysates of Pkr+/+ob/ob (E) and Pkr/ob/ob (F) mice exogenously expressing a control gene (GUS) or TRBP. The graph on the right shows the
quantification of the results. Data are shown as the mean ± SEM. *p < 0.05.cholesterol, and very-low-density lipoprotein (VLDL) inPkr/ob/
ob mice were significantly reduced compared to those in
Pkr+/+ob/ob controls (Figures S4A–S4C).
We next assessed the contribution of PKR to obesity-induced
JNK activity and eIF2a phosphorylation in this setting. As shown
in Figure 5F, JNK activation was highly induced in liver of
Pkr+/+ob/ob compared to that of lean mice, as expected (Hiro-
sumi et al., 2002; Sreejayan et al., 2008). In contrast, activation
levels of JNK in liver of Pkr/ob/obmice were significantly lower
than those detected in Pkr+/+ob/ob controls. Similarly, the
increased eIF2a phosphorylation seen in the liver of ob/ob
mice in numerous independent studies (Ozcan et al., 2004; Sree-
jayan et al., 2008; Tsutsumi et al., 2011; Yang et al., 2010) was
significantly reduced to levels close to lean controls upon loss
of PKR (Figure 5G). Of note, activation of PERK, the ER resident
eIF2a kinase, remained elevated in liver of Pkr/ob/ob mice302 Cell Reports 11, 295–307, April 14, 2015 ª2015 The Authors(Figure S4D). These data indicate that PKR is the dominant
mediator of hepatic JNK activation and eIF2a phosphorylation
in obesity. In addition, consistent with previous observations
(Nakamura et al., 2010, 2014), we also confirmed that obesity-
induced IRS1 serine phosphorylation levels were decreased in
the absence of PKR in this setting (Figure 5H).
We next utilized the ob/ob model to investigate the role of
TRBP in obesity using adenovirus-mediated gene transfer to
exogenously express TRBP in liver and examine the effects on
glucosemetabolism, JNK activation, and eIF2a phosphorylation.
The ob/ob mice overexpressing TRBP in liver exhibited similar
weight gain and liver weight compared to a control group (Fig-
ures 6A and 6B). However, enhanced expression of TRBP in liver
of ob/obmice resulted in a small but significant increase in fast-
ing glucose levels (Figure 6C) and a further deterioration of
glucose tolerance as determined by GTTs compared to control
mice (Figure 6D). Importantly, we observed that TRBP overex-
pression in liver led to further induction of JNK activation and a
further increase in hepatic eIF2a phosphorylation compared to
the controls (Figure 6E). Next, we asked whether the TRBP-
induced JNK activation and eIF2a phosphorylation were depen-
dent on PKR function using adenoviral expression systems.
As shown in Figure 6F, PKR-deficient ob/ob mice showed
decreased levels of JNK activation and eIF2a phosphorylation
compared to a PKR-intact control group virally expressing a con-
trol gene (Gus). When TRBP was exogenously expressed in liver
of PKR-deficient ob/ob mice, the levels of phosphorylated JNK
were partially recovered, but eIF2a phosphorylation levels re-
mained low. These data suggest that TRBP requires PKR for
induction of eIF2a phosphorylation but may mediate JNK activa-
tion in both PKR-dependent and independent manners.
Physiological Roles of TRBP in Obese Liver
Taken together, our observations demonstrate that the com-
plex formation between TRBP and PKR may promote PKR’s
adversemetabolic functions. To further explore the physiological
relevance of the PKR-TRBP axis in obesity, we designed and
established a short hairpin RNA (shRNA)-mediated TRBP knock-
down system in which TRBP expression levels in cells were re-
duced 85% (data not shown). Palmitate-induced PKR activa-
tion was diminished by shRNA-mediated suppression of TRBP
(Figure 7A), consistent with our observations in TRBP-deficient
fibroblasts (Figure 3E). To investigate the consequence of re-
duced TRBP in obesity, we used an adenoviral system to ex-
press shRNAs against TRBP in the liver of ob/ob mice, which
reduced TRBP protein expression up to 90% (Figure 7B). In
this setting, suppression of hepatic TRBP led to reduced steato-
sis accompanied by decreased liver weight (Figure 7C), although
body weight remained similar to that of control mice (Figure 7D).
Suppression of hepatic TRBP also resulted in a significant reduc-
tion in fasting blood glucose levels and improved glucose toler-
ance indicating improved glucose metabolism (Figures 7E and
7F). This improvement was observed with two independent
shRNA constructs, which achieved similar knockdown effi-
ciency. Consistent with these metabolic outcomes, TRBP sup-
pression resulted in significant downregulation of genes involved
in hepatic glucose production (G6Pase and PEPCK) as well as
lipogenesis (FAS and SCD1) (Figure 7G). Importantly, expression
levels of inflammatory cytokines (tumor necrosis factor a and
interleukin-1b) and ER stress markers (Grp78 and CHOP) were
also significantly reduced following the suppression of hepatic
TRBP, while expression levels of b-oxidation-related genes
(CPT1 and PGC1a) remained unaffected (Figure 7G).
As inflammatory responses, which were assessed by PKR ac-
tivity and inflammatory cytokine expression, were downregu-
lated upon suppression of hepatic TRBP expression in ob/ob
mice, we assessed the effects of hepatic TRBP knockdown on
JNK activation. Consistent with results obtained from PKR-defi-
cient ob/ob mice, suppression of hepatic TRBP significantly
reduced JNK activity assessed by phosphorylation levels of
JNK (Figure 7H). In addition, reduced expression of hepatic
TRBP resulted in a significant reduction of eIF2a phosphoryla-
tion in liver of ob/ob mice (Figure 7H), similar to what was
observed in the PKR-deficient ob/ob mice (Figures 5F and 5G).Wealso examined the impact of these alterations on IRS-1 phos-
phorylation and insulin action in liver. TRBP suppression in
obese mice resulted in a significant reduction of IRS1 serine
phosphorylation levels (Figure 7I) and restoration of insulin-
induced AKT phosphorylation in liver tissue (Figure 7J).
DISCUSSION
Until recently, the main role of PKR has been believed to be the
suppression of global protein translation of host cells through
induction of eIF2a phosphorylation upon pathogen infection
(Garcı´a et al., 2006). It is now clear that PKR is also a critical regu-
lator of metabolic homeostasis, placing this enzyme at a critical
juncture in immunometabolic pathways (Carvalho-Filho et al.,
2012; Nakamura et al., 2010). Here, we demonstrate that PKR
can interact with RLC components to integratemetabolic signals
with eIF2a phosphorylation and inflammatory responses. This
is not only consistent with the need of host cells to have more
efficient and diverse intrinsic strategies to prevent amplification
of pathogens but also provides a mechanism by which intrinsic
or extrinsic metabolic exposures and stress are linked to
immune outputs. As in the case of pathogen exposure, PKR co-
ordinates the eIF2a phosphorylation-mediated suppression of
protein translation with the induction of inflammatory responses
upon exposure to excess nutrients and energy.
Phosphorylation of eIF2a is considered an important protective
event to restore homeostasis upon ER malfunction induced by
stresses such as virus infection, accumulation of unfolded ormis-
folded proteins, lipid overloading, and inflammation (Fu et al.,
2011; Holcik and Sonenberg, 2005; Ron and Walter, 2007;
Hotamisligil, 2010). This in turn is believed to lead to a reduction
of the ER burden and conservation of cellular energy sources
needed to sustain vital processes. If the cellular stress levels are
beyond a threshold, cells activate apoptotic or maladaptive path-
ways such as JNKandp38signaling (Wagner andNebreda, 2009;
Williams, 2001; Vallerie and Hotamisligil, 2010). Under obesity-
induced chronicmetabolic stress, these protective andmaladap-
tive mechanisms co-exist, and thus opposing cellular stress re-
sponses compromise the molecular networks that affect regula-
tion of systemic metabolism (Hirosumi et al., 2002; Liu and Cao,
2009; Vallerie and Hotamsilgil, 2010). Therefore, disordered
signaling events may occur and be amplified in obesity, leading
to disruption of metabolic homeostasis. It is of critical importance
to understand the key regulatory events maintaining chronic
stress signaling, and our observations position PKR as a potential
regulator of this metastable state.
Signaling through eIF2a is involved in a variety of molecular
networks including regulation of development, organelle func-
tion, inflammation, and metabolic homeostasis (Holcik and
Sonenberg, 2005; Malhi and Kaufman, 2011; Vallerie and Hota-
misligil, 2010). Sustained phosphorylation of eIF2a has been
observed as a feature of obesity and insulin resistance in both
experimental systems and humans (Gregor et al., 2009; Oyado-
mari et al., 2008; Ozcan et al., 2004, 2006; Sharma et al., 2008;
Sreejayan et al., 2008; Tsutsumi et al., 2011; Wang et al., 2009;
Zhou et al., 2009), and this has previously been attributed exclu-
sively to ER stress-related activation of PERK function (Birken-
feld et al., 2011; Cummings et al., 2011; Delibegovic et al.,Cell Reports 11, 295–307, April 14, 2015 ª2015 The Authors 303
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Figure 7. Physiological Roles of Hepatic TRBP in Obesity
(A) Effects of TRBP suppression on palmitate-induced PKR activation. TRBP expression inPkr/MEFs reconstitutedwith Flag-taggedWTPKRwere reduced by
adenovirus-mediated shRNAs. These cells were treated with 100 mM palmitate for 2 hr, followed by immunoprecipitation with anti-Flag antibody, and in vitro
kinase assay with recombinant eIF2a protein. The graph on the right shows the quantification of the results. Data are shown as the mean ± SEM. *p < 0.05. See
also Table S3.
(B) Effects of hepatic TRBP suppression in ob/ob mice on TRBP, PKR, and Dicer expression following transduction of adenovirus-mediated control shRNA to
LacZ. Liver tissue lysates were analyzed by immunoblotting with antibodies as indicated. To analyze the levels of PKR- and Dicer-interacting TRBP, the tissue
lysates were immunoprecipitated with anti-TRBP antibody, followed by immunoblotting with antibodies as indicated.
(C and D) Effects of hepatic TRBP reduction in ob/ob mice on liver weight (C) and body weight (D). Data are shown as the mean ± SEM (n = 8). *p < 0.05.
(E) Effect of hepatic TRBP knockdown in ob/ob mice on fasting blood glucose. Data are shown as the mean ± SEM (n = 8). *p < 0.05.
(F) Effects of hepatic TRBP suppression on systemic glucose metabolism assessed by glucose tolerance tests. Hepatic TRBP was reduced using two different
shRNA constructs introduced by adenovirus-mediated gene transfer in ob/ob liver. Data are shown as the mean ± SEM (n = 8). *p < 0.05.
(G) Effects of hepatic TRBP suppression in ob/ob mice on expression of key regulators of liver function. Expression levels of the genes were detected by
quantitative PCR method. Data are shown as the mean ± SEM (n = 8). *p < 0.05. See also Table S4.
(H) Hepatic TRBP knockdown results in reduced, eIF2a and JNK phosphorylation levels in obese liver.
(legend continued on next page)
304 Cell Reports 11, 295–307, April 14, 2015 ª2015 The Authors
2009; Gregor et al., 2009; Oyadomari et al., 2008; Ozcan et al.,
2004; Sharma et al., 2008; Sreejayan et al., 2008). However,
our findings demonstrate that PKR dominates this regulation in
obese liver. Despite the fact thatmolecular networks of ER stress
responses including PERK remain active in Pkr/ob/ob mice,
eIF2a phosphorylation levels were significantly diminished
without a change in body weight. These findings imply that (1)
PERK may be engaged in other molecular regulations beyond
eIF2a phosphorylation in obese tissues; (2) obesity causes com-
plex cellular stresses, namely metaflammation, and that PKR
integrates these inputs into induction of eIF2a phosphorylation
and metabolic outcomes; and (3) regulatory factors involved in
PKR activation play critical roles as interfaces linking transla-
tional deregulation to metabolic dysfunction in obesity. In this
regard, identification of Dicer and TRBP as components of the
activated PKR complex strongly indicates the possibility of
involvement of endogenous double-stranded RNA species,
such as snoRNAs (O.A. Youssef, S.A. Safran, T.N., D.A. Nix,
G.S.H., B.L. Bass, unpublished data), in addition to potential
microbe-derived ligands, in PKR activation in obesity and
possibly other metabolic stresses, and identifying these ligands
will be an interesting opportunity to pursue in future studies. Inte-
grating the TRBP-RLC and PKR-eIF2a axes could be an efficient
strategy that allows cells to respond collectively to environ-
mental and metabolic perturbations. Our data raise the possibil-
ity that in certain stress conditions, TRBP and RLC components
are involved in the regulation of certain RNA species that induce
PKR activation leading to eIF2a phosphorylation. In addition, as
protein synthesis is tightly linked to cellular energy consumption,
this mechanism may serve to modulate energy utilization in
response to metabolic stress in obesity.
TRBP is a unique dsRNA-binding protein that has at least two
molecular functions: enhancing microRNA (miRNA) maturation
processes as a component of the RLC and regulating inflamma-
tory responses by modifying PKR activity. Importantly, these
TRBP functions are modulated by phosphorylation induced by
mitogen-activated protein kinases (MAPKs) such as ERK and
JNK, which are activated in the liver in obesity and involved in
pathogenesis of obesity-induced metabolic diseases (Hirosumi
et al., 2002; Jiao et al., 2013). In the setting of metaflammation,
TRBP leads to PKR activation as well as enhancement of general
miRNA maturation processing (Paroo et al., 2009). Co-existence
of positive and negative regulatory capacity in RNA binding mol-
ecules such as PACT has been reported before and attributed to
the stoichiometry of the intermolecular interactions (Clerzius
et al., 2013). Here, we provide evidence that this dual function
of TRBP, at least in part, is also regulated by JNK-MAPK-medi-
ated phosphorylation. It is worth noting that obesity constitutes
a condition of chronic JNK activation, which through TRBP
phosphorylation and other mechanisms contributes to sustained
PKR activity and potentially other outcomes such as increased
general miRNA expression (Kornfeld et al., 2013), which are
all observed simultaneously. Our finding that TRBP suppression(I) Serine phosphorylation level of IRS1 was detected by an anti-phospho IRS1 an
of the results. Data are shown as the mean ± SEM. *p < 0.05.
(J) Enhanced insulin signaling, which was assessed by anti-phospho-specific AKT
right shows the quantification of insulin-induced phosphorylation levels of Akt. Dresults in alleviation of obesity-induced hepatic steatosis and
glucose intolerance suggests a direct role for TRBP in the patho-
genesis of obesity and chronic metabolic complications. Recent
research suggests thatmiRNAbiogenesis is critical for protecting
cells from ER-stress-induced cell death (Cawley et al., 2013);
therefore, by acting in this pathway aswell bymediating JNKacti-
vation and eIF2a phosphorylation, TRBP may modulate cellular
resistance to metaflammation or its resolution. In chronic
metabolic stress conditions, these TRBP-mediated events may
contribute to exacerbation of inflammatory responses and dete-
riorate metabolic homeostasis beyond their adaptive effects.
Notably, PKR activity is highly correlated with JNK activation,
and in turn, JNKmay phosphorylate TRBP, indicating a regulato-
ry loop between these kinases via TRBP, which may be key to
their activation in metabolic context. As the assembly of PKR
with RLC is highly associated with PKR and JNK activation,
and because PKR can also participate in inflammatory activity
(Carvalho-Filho et al., 2012; Lu et al., 2012; Nakamura et al.,
2010), TRBP phosphorylation may be a core component of a
signaling node representing themetabolic inflammasome (meta-
flammasome). Finally, our findings indicate that the inhibition of
PKR and TRBP function may result in simultaneous relief from
multiple stress responses and may provide new opportunities
for clinical applications against chronic stress-related diseases,
including obesity-induced metabolic disease and cancer.EXPERIMENTAL PROCEDURES
Detailed procedures can be found in Supplemental Experimental Procedures.
Mice
Animal care and experimental procedures were performed with approval from
the animal care committees of Harvard University. Two different types of tar-
geted mutations of PKR have been established and reported in mice: RNA-
binding domain-defective and kinase domain-defective models (Abraham
et al., 1999; Baltzis et al., 2002). In this study, the kinase domain-defective
PKR-deficient mice were used, after breeding into the C57Bl/6J genetic back-
ground and validation by genome-wide SNP analysis. PKR-deficient mice
were then intercrossed with heterozygote animals in the ob (leptin) locus in
order to generate PKR-deficient ob/ob mice. GTTs were performed by intra-
peritoneal glucose injection (0.5 g/kg) following an overnight food withdrawal.
ITTs were performed by intraperitoneal insulin injection (3 IU/kg) following a
6 hr daytime food withdrawal. After 10 weeks, these mice were sacrificed
and tissues were collected for further analysis. Total body fat mass was as-
sessed by dual energy X-ray absorptiometry (DEXA; PIXImus). Adenovirus car-
rying HA-tagged PKR, GFP, LacZ-shRNA, or TRBP-shRNA was delivered into
the ob/ob or lean mice intravenously at a titer of 33 1011 virus particles/mice.
Serum insulin was measured by an ELISA purchased from Alpco. Serum tri-
glyceride, cholesterol, and very-low-density lipoprotein levels were measured
with Piccolo-lipid panel plus, purchased from Abaxis.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.03.021.tibody recognizing residue 307. The graph on the right shows the quantification
antibody, observed in TRBP-knockdown liver of ob/obmice. The graph on the
ata are shown as the mean ± SEM. *p < 0.05.
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